Canine Borreliosis: The Science of Lyme Disease in Dogs
Canine borreliosis (Lyme disease) explained through veterinary science—symptoms, pathophysiology, diagnosis, treatment costs.
Understanding the Pathogen: How Borrelia burgdorferi Invades the Canine Body
Canine borreliosis is fundamentally a story of bacterial evasion. Borrelia burgdorferi is a spirochete—a corkscrew-shaped bacterium uniquely adapted to survive in both tick and mammalian hosts. When an infected Ixodes scapularis (deer tick) attaches to a dog and begins feeding, the bacteria undergo a remarkable physiological transformation.
The 36-Hour Transmission Window
Research published in the Journal of Clinical Microbiology established that B. burgdorferi resides in the tick's midgut during its dormant phase, expressing a surface protein called OspA (Outer Surface Protein A). As the tick feeds and blood enters the midgut, the bacteria sense the change in temperature and pH, triggering a genetic shift: they downregulate OspA and upregulate OspC, a protein that enables them to migrate to the tick's salivary glands and enter the host.
This migration process takes approximately 36–48 hours of continuous tick attachment. This is why prompt tick removal—within 24 hours of attachment—dramatically reduces transmission risk. The bacteria then disseminate through the dog's bloodstream, preferentially colonizing connective tissues, joint capsules, and sometimes the kidneys.
Once inside the canine host, B. burgdorferi employs immune evasion strategies that make it notoriously difficult for the body to clear. The spirochete can alter its surface proteins (a process called antigenic variation), essentially changing its "uniform" so antibodies produced against one variant don't recognize the next. It also binds host complement-regulatory proteins, effectively cloaking itself in the dog's own immune markers.
Why Dogs and Ticks: An Evolutionary Mismatch
Evolutionary context: Ticks have parasitized mammals for over 99 million years (fossil evidence from Cretaceous amber). Canids, as cursorial predators roaming grassland and forest-edge habitats, have coexisted with Ixodes species throughout their evolutionary history. However, the dense suburban reforestation of the past 70 years—and the explosion of white-tailed deer populations from roughly 500,000 in 1900 to over 30 million today—has created tick densities that far exceed historical baselines. Dogs living in modern landscapes face exposure pressure their ancestors never encountered.
The white-footed mouse (Peromyscus leucopus) serves as the primary reservoir host for B. burgdorferi in eastern North America. Larval ticks feed on infected mice, acquire the bacteria, and transmit them during their next blood meal—often on a dog or human. Unlike some wildlife species, white-footed mice tolerate high spirochete loads without illness, making them efficient "amplifiers" in the enzootic cycle.
Wolves and wild canids likely experienced tick-borne infections historically, but their lower population density and broader ranging patterns limited concentrated exposure. Modern domestic dogs, particularly those in the Northeast, Upper Midwest, and Pacific Northwest of the United States, live in tick-saturated environments that represent an evolutionary novelty. This ecological mismatch explains why canine borreliosis has emerged as one of the most common vector-borne diseases in North American dogs.
The Immune Response: Why Most Dogs Don't Get Sick
One of the most scientifically fascinating aspects of canine borreliosis is that approximately 90–95% of infected dogs never develop clinical signs. Seroprevalence studies in endemic areas like Connecticut and Minnesota show that 50–75% of unvaccinated dogs test antibody-positive for B. burgdorferi exposure, yet veterinary clinics see clinical Lyme disease in only a fraction of these animals.
The physiological explanation involves the canine innate immune system's ability to contain—though not eliminate—the spirochete. Dogs mount a robust inflammatory response that walls off bacteria in connective tissue, preventing systemic dissemination. The complement system, particularly the alternative pathway, appears more effective in dogs than in humans at limiting spirochete replication. This species-level difference is why humans develop chronic Lyme complications (neuroborreliosis, cardiac involvement) far more frequently than dogs.
However, this containment comes at a cost. In the 5–10% of dogs that develop clinical borreliosis, the immune response itself drives pathology. The shifting lameness characteristic of Lyme arthritis results from immune complex deposition in joint synovium, not from direct bacterial destruction of cartilage. The inflammation is the disease, not just a response to it.
| Category | Symptoms | Onset Timeline | Estimated Frequency |
|---|---|---|---|
| Subclinical (most common) | No observable signs; positive antibody test | N/A | 90–95% of infections |
| Acute Lyme arthritis | Shifting-leg lameness, joint swelling, fever (103–105°F / 39.4–40.6°C), lethargy, anorexia | 2–5 months post-bite | 5–10% of infections |
| Lyme nephritis | Proteinuria, vomiting, weight loss, edema, renal failure | Variable; months to years | <1% of infections |
| Neurologic/cardiac | Seizures, facial nerve paralysis, arrhythmias | Rare and poorly documented | Extremely rare in dogs |
Lyme Nephritis: The Deadly Exception
While acute Lyme arthritis is painful but treatable, Lyme nephritis represents the most dangerous manifestation of canine borreliosis. This immune-mediated kidney disease occurs when B. burgdorferi antigens trigger glomerulonephritis—inflammation of the kidney's filtering units. The resulting protein-losing nephropathy can progress rapidly to fatal renal failure.
According to the Merck Veterinary Manual, certain breeds show disproportionate susceptibility to Lyme nephritis. Labrador Retrievers and Golden Retrievers appear overrepresented in case reports, suggesting a possible genetic predisposition involving immune regulation genes. The condition carries a guarded to poor prognosis, with many affected dogs dying within weeks of diagnosis despite aggressive treatment.
The mechanism involves circulating immune complexes (antigen-antibody clumps) depositing in glomerular basement membranes. This activates complement cascades that damage the filtration barrier, allowing protein to leak into urine. Once significant proteinuria develops, the cascade becomes self-perpetuating even if the original bacterial trigger is eliminated with antibiotics.
- Sudden lameness with fever in a tick-endemic area
- Lameness that shifts between different legs over days
- Known tick exposure followed by lethargy and appetite loss 2–5 months later
- Increased thirst and urination combined with weight loss (possible nephritis)
- Swollen, warm, painful joints
Early antibiotic treatment (doxycycline at 5 mg/kg twice daily for 28–30 days) resolves clinical signs in most dogs within 24–48 hours of starting therapy.
Diagnosis: Decoding the Tests
Diagnosing canine borreliosis requires understanding what tests actually measure, because a positive antibody test alone does not confirm active disease. The AVMA recommends a combination of exposure history, clinical signs, and laboratory findings.
SNAP 4Dx Plus (in-clinic ELISA): This rapid test detects antibodies to the C6 peptide—a surface protein fragment specific to B. burgdorferi. A positive result confirms exposure but cannot distinguish between past resolved infection, current subclinical infection, and active clinical disease. In endemic areas, up to 75% of healthy dogs may test C6-positive.
Quantitative C6 Antibody Test (Quant C6): This laboratory test measures the actual concentration of anti-C6 antibodies. High titers (>30 units/mL) in a symptomatic dog support a diagnosis of active borreliosis. Declining titers over 6 months suggest successful treatment or natural resolution.
PCR Testing: Polymerase chain reaction detects bacterial DNA in synovial fluid or tissue biopsies. While highly specific, sensitivity is low because spirochetes localize unevenly in tissues. A negative PCR does not rule out infection.
Urinalysis: Essential for every C6-positive dog, even without symptoms. Proteinuria (elevated urine protein:creatinine ratio, UPC >0.5) may indicate early Lyme nephritis and warrants immediate further investigation.
| Test | What It Detects | Turnaround | Typical Cost | Limitations |
|---|---|---|---|---|
| SNAP 4Dx Plus | C6 antibodies (qualitative) | 8 minutes (in-clinic) | $35–$65 (often bundled with heartworm test) | Cannot distinguish active vs. past infection |
| Quant C6 | C6 antibody concentration | 3–5 business days | $65–$110 | Requires lab submission; still measures exposure, not active disease alone |
| PCR (synovial fluid) | Bacterial DNA | 3–7 business days | $90–$180 | Low sensitivity; invasive sample collection |
| Urinalysis with UPC | Proteinuria (nephritis screening) | Same day to 2 days | $45–$85 | Non-specific; other diseases also cause proteinuria |
Myths vs. Evidence: Clearing Up Common Misconceptions
| Myth | Evidence-Based Fact |
|---|---|
| "My dog tested positive for Lyme, so he needs antibiotics immediately." | A positive C6 test indicates exposure, not active disease. The American College of Veterinary Internal Medicine (ACVIM) consensus statement recommends treating only dogs showing clinical signs, plus monitoring asymptomatic C6-positive dogs with regular urinalysis for nephritis screening. |
| "If I remove a tick within a few hours, my dog is safe." | Correct—transmission typically requires 36–48 hours of attachment. However, other tick-borne pathogens like Anaplasma phagocytophilum can transmit in as little as 12–24 hours. Always submit ticks for identification and monitor for symptoms. |
| "Lyme disease causes chronic, lifelong lameness in dogs." | Lyme arthritis typically responds dramatically to a 28–30 day course of doxycycline. Persistent lameness after treatment should prompt investigation for other causes (orthopedic disease, immune-mediated polyarthritis, other tick-borne coinfections). |
| "My dog can give me Lyme disease." | B. burgdorferi is not directly transmissible from dogs to humans. However, dogs bring infected ticks into the home environment, increasing human exposure risk indirectly. Use year-round tick preventives on all pets. |
| "The Lyme vaccine doesn't work, so why bother?" | Vaccines targeting OspA induce antibodies that neutralize spirochetes within the feeding tick itself—before they enter the dog. Field studies show approximately 80–90% efficacy when combined with tick control. Vaccination is recommended for dogs in endemic areas, particularly those with outdoor lifestyles. |
Breed Variations and Risk Factors
While any dog can contract canine borreliosis, breed and lifestyle significantly influence risk profiles:
- Sporting and working breeds (Labrador Retrievers, German Shorthaired Pointers, Brittany Spaniels) face higher exposure due to time spent in tick-dense field and forest environments.
- Labrador Retrievers and Golden Retrievers are disproportionately affected by Lyme nephritis, suggesting a breed-specific immune dysregulation that researchers are still investigating.
- Small companion breeds may have lower exposure rates but are not immune—ticks thrive in suburban yards and urban parks.
- Intact males appear slightly overrepresented in Lyme nephritis case series, though the mechanism is unclear and may reflect ranging behavior rather than hormonal influence.
Geographic risk remains the strongest predictor. The CDC identifies the Northeast (Connecticut through Maine), Upper Midwest (Minnesota, Wisconsin), and northern California as highest-risk zones. However, Ixodes tick ranges have expanded significantly over the past decade, with established populations now documented in parts of the Southeast, Ohio Valley, and Great Plains where they were previously absent.
Prevention Science: Building a Multi-Layer Defense
Evidence-Based Prevention Protocol
- Isoxazoline-class oral preventives (afoxolaner, fluralaner, sarolaner) kill attached ticks within 12–24 hours, typically before B. burgdorferi transmission occurs. Monthly dosing costs $18–$30 per dose depending on dog weight and brand (NexGard, Bravecto, Simparica).
- Seresto collar (imidacloprid + flumethrin) provides 8-month tick repellency and kill. Cost: $65–$90 per collar. Repellency reduces tick attachment frequency, adding a layer beyond kill-after-attachment.
- Lyme vaccination (recombinant OspA or bacterin-based) recommended annually for dogs in endemic areas. Initial series: two doses 2–4 weeks apart, then annual boosters. Cost: $25–$45 per dose. Discuss with your veterinarian whether vaccination is appropriate for your dog's risk profile.
- Daily tick checks after outdoor activity, focusing on ears, axillae, groin, and between toes. Remove ticks with fine-pointed tweezers grasped at skin level, pulling straight upward with steady pressure. Do not use heat, petroleum jelly, or essential oils—these can cause the tick to regurgitate gut contents into the wound.
- Yard management: Keep grass mowed, create gravel or wood-chip barriers between lawn and wooded areas (ticks desiccate quickly on dry surfaces), and discourage deer access with fencing.
The concept of "prevention stacking" reflects how veterinary parasitologists now approach tick-borne disease. No single intervention is 100% effective, but combining a fast-kill oral preventive, vaccination in endemic areas, and environmental management reduces cumulative risk to very low levels. The cost of comprehensive annual prevention ($250–$500 depending on products chosen and dog size) is substantially lower than treating Lyme nephritis, which can exceed $3,000–$8,000 in hospitalization, IV fluids, and specialty nephrology consultation.
Frequently Asked Questions
Can dogs fully recover from canine borreliosis?
Yes—dogs with acute Lyme arthritis typically recover fully with a 28–30 day course of doxycycline (5 mg/kg orally, twice daily). Clinical improvement is often seen within 24–48 hours. However, antibiotics may not completely eliminate all spirochetes from tissues, and some dogs remain antibody-positive indefinitely. This persistent seropositivity does not necessarily indicate treatment failure or ongoing infection.
How is canine borreliosis different from Lyme disease in humans?
Several key differences exist. Dogs rarely develop the characteristic erythema migrans (bullseye rash) seen in 70–80% of human cases. Neurologic and cardiac manifestations, while devastating when they occur in humans, are exceedingly rare in dogs. The canine immune system appears more effective at containing spirochete dissemination. However, dogs uniquely develop Lyme nephritis, a severe kidney complication with no direct human equivalent.
Is canine borreliosis contagious between dogs or from dogs to people?
No. Borrelia burgdorferi requires the tick vector for transmission. Direct dog-to-dog, dog-to-human, or dog-to-cat transmission does not occur. The risk to humans in a household with a Lyme-positive dog is indirect: the same tick-infested environment that exposed the dog also exposes the human family members.
What does it mean when my dog's Lyme test is positive but he seems fine?
A positive C6 SNAP test in an asymptomatic dog indicates prior exposure to B. burgdorferi. Current ACVIM consensus guidelines recommend: (1) performing a urinalysis with UPC ratio to screen for subclinical nephritis, (2) monitoring for clinical signs over subsequent months, and (3) ensuring year-round tick prevention is in place. Routine antibiotic treatment of asymptomatic seropositive dogs is not recommended, as it provides no proven benefit and contributes to antimicrobial resistance.
Can my dog get borreliosis more than once?
Natural infection does not produce sterilizing immunity, meaning reinfection is possible if the dog is bitten again by an infected tick. This is why vaccination and tick prevention remain important even for dogs previously diagnosed and treated. The Lyme vaccine stimulates production of borreliacidal antibodies that target spirochetes within the feeding tick, providing a different mechanism of protection than natural immune memory.
Related Tick-Borne Diseases to Watch For
Canine borreliosis rarely travels alone. Ixodes ticks can simultaneously transmit multiple pathogens, and co-infections may complicate diagnosis and treatment:
- Anaplasmosis (Anaplasma phagocytophilum): Causes fever, lethargy, and thrombocytopenia. Often co-occurs with Lyme in the same geographic regions. The SNAP 4Dx Plus tests for both simultaneously.
- Babesiosis (Babesia microti): A protozoan parasite causing hemolytic anemia. Transmitted by the same tick species. Requires different treatment (imidocarb dipropionate or atovaquone + azithromycin).
- Powassan virus: A rare but serious flavivirus transmitted by Ixodes ticks. While primarily a human concern, awareness of co-circulating pathogens underscores the importance of tick prevention.
If your dog tests positive for B. burgdorferi, ask your veterinarian about screening for Anaplasma and Ehrlichia as well. The SNAP 4Dx Plus already covers these, but clinical interpretation requires veterinary expertise to determine which positive results warrant treatment and which represent resolved past exposures.
Canine borreliosis illustrates a broader principle in veterinary infectious disease: exposure does not equal illness, and a positive test is the beginning of a diagnostic conversation, not a verdict. Working closely with your veterinarian to interpret test results in the context of your dog's clinical picture, geographic risk, and lifestyle is the most scientifically sound approach to managing this complex disease.
Tom Renshaw
All our authors care for dogs every day — read more of their work on the authors page.
